Pharmacovigilance: profile and notifications of the adverse drug reaction in a teaching hospital
DOI:
https://doi.org/10.30968/rbfhss.2023.142.0932Abstract
Objective: To identify the profile of adverse drug reactions (ADRs) in a tertiary public teaching hospital after the inclusion of active search, through screeners, in the pharmacovigilance service, as well from inform managers about the epidemiological data of ADRs. Method: Observational, descriptive, and exploratory study conducted in a tertiary teaching hospital in western Paraná, between July and December 2018. The search was performed by consulting the Microsoft Office Excel® program database of the Pharmacovigilance Service and the Quality and Patient Safety Sector (SQSP). It identified the profile of adverse drug reactions and notifications to the pharmacovigilance service regarding the system of spontaneous notification and tracers by active search, as well as made a brief survey of costs related to the topic. Results: In the period studied 536 notifications were reported, 74 of these were considered adverse reactions. The hospital team that reported most frequently was the nursing staff. The screeners related to antiallergic and antidotes to anticoagulants were the most sensitive with a positive predictive value of 9 and 3%, respectively. The Emergency Room (ER) was the ward with the highest number of notifications (215), mainly due to the use of the screeners. The drugs with the highest prevalence were morphine (17%) and dipyrone (10%). The exclusive cost of the reactions was R$ 1,097.56. Conclusion: The conclusion is that this study allowed the characterization of the main ADR tracers after the inclusion of active search and that in-hospital actions are needed to avoid underreporting in order to ensure efficacy and therapeutic safety.
Downloads
References
Classen DC, Resar R, Griffin F, et al. “Global trigger tool” shows that adverse events in hospitals may be ten times greater than previously measured. Health Aff. 2011;30(4):581–9. DOI: 10.1377/hlthaff.2011.0190
Leite SM, Kessler CN, Leuschle V, et al. Eventos adversos a medicamentos em ambiente hospitalar. Revista Espaço Ciência & Saúde. 2016 Disponível em: http://revistaeletronica.unicruz.edu.br/index.php/enfermagem/article/view/5252
Valdiero KS. Proposta de um sistema de farmacovigilância para um hospital municipal de grande porte da cidade do Rio de Janeiro. 2016. Disponível em: https://app.uff.br/riuff/handle/1/10945
Rozenfeld S, Giordani F, Coelho S. Eventos adversos a medicamentos em hospital terciario: estudo piloto com rastreadores. Rev Saude Publica. 2013;47(6):1102–11. DOI: 10.1590/S0034-8910.2013047004735
Modesto ACF, Ferreira TXAM, Provin MP, et al. Reações Adversas a Medicamentos e Farmacovigilância: Conhecimentos e Condutas de Profissionais de Saúde de um Hospital da Rede Sentinela. Rev Bras Educ Med. 2016;40(3):401–10. DOI: 10.1590/1981-52712015v40n3e01502015
Rodrigues BLM, Lima VL de A, Gomes J de S, et al. Avaliação de eventos adversos relacionados a medicamentos como indicador de implantação de um centro de informações sobre medicamentos. Rev Eletrônica Acervo Saúde. 2019; 11(7):614. DOI: 10.25248/reas.e614.2019
Basile LC, Santos A Dos, Stelzer LB, et al. Análise das ocorrências de incidentes relacionados aos medicamentos potencialmente perigosos dispensados em hospital de ensino. Rev Gauch Enferm. 2019. DOI:10.1590/1983-1447.2019.20180220
dos Santos L. Aline. CCSA, Batista C. Claudia. Perfil das reações adversas a medicamentos notificadas em um Hospital Universitário. Rev Bras Farm Hosp Serv Saúde São Paulo. 2015;6 n.3(3):12–7.
Duarte S da CM, Stipp MAC, Silva MM da, et al. Eventos adversos e segurança na assistência de enfermagem. Rev Bras Enferm. 2015;68(1):144–54. DOI: 10.1590/0034-7167.2015680120p
Portaria MS No 529, de 1o de abril de 2013 [Internet]. 529 2013. Available from: http://bvsms.saude.gov.br/bvs/saudelegis/gm/2013/prt0529_01_04_2013.html
Silva LT, Modesto ACF, Martins RR, et al. The Brazilian Portuguese version of the Pediatric Trigger Toolkit is applicable to measure the occurrence of adverse drug events in Brazilian pediatric inpatients. J Pediatr. 2019;95(1):61-8. DOI: 10.1016/j.jpedp.2018.01.003
de Lima Neto AV, Antunes da Silva F, De Oliveira Lima Brito GM, et al. Analysis of notifications of adverse events in a private hospital. Enfermería Glob. 2019;18(3):314–43. DOI: 10.6018/eglobal.18.3.325571
Roque KE, Melo ECP. Avaliação dos eventos adversos a medicamentos no contexto hospitalar. Esc Anna Nery. 2012;16(1):121–7. DOI: 10.1590/S141481452012000100016
Mycyk MB, McDaniel MR, Fotis MA, et al. Hospitalwide adverse drug events before and after limiting weekly work hours of medical residents to 80. Am J Heal Pharm. 2005;62(15):1592–5. DOI: 10.2146/ajhp040527
Cano FG, Rozenfeld S. Adverse drug events in hospitals: a systematic review. Cad Saude Publica. 2009;25(suppl 3):S360–72. DOI: 10.1590/S0102-311X2009001500003
Allué N, Chiarello P, Bernal Delgado E, et al. Impacto económico de los eventos adversos en los hospitales españoles a partir del Conjunto Mínimo Básico de Datos. Gac Sanit. 2014;28(1):48–54. DOI: 10.1016/j.gaceta.2013.06.004
Aranaz-Andres JM, Aibar-Remon C, Limon-Ramirez R, et al. Prevalence of adverse events in the hospitals of five Latin American countries: results of the “Iberoamerican study of adverse events” (IBEAS). BMJ Qual Saf. 2011;20(12):1043–51. DOI: 10.1136/bmjqs.2011.051284
Mendes W, Martins M, Rozenfeld S, et al. The assessment of adverse events in hospitals in Brazil. Int J Qual Heal Care. 2009;21(4):279–84. DOI:10.1093/intqhc/mzp022.
Mattar ALR. Avaliação da notificação de eventos adversos em um hospital universitário do interior de Minas Gerais. [Ribeirão Preto]: Universidade de São Paulo; 2018.
Em PDEP, Ciências M. Reações Adversas a Medicamentos: uma coorte em hospital universitário Reações Adversas a Medicamentos: uma coorte em hospital universitário. 2005. Available from: https://www.lume.ufrgs.br/handle/10183/6164
ANVISA. O que é farmacovigilância? - Busca - Anvisa [Internet]. ANVISA. [cited 2019 Oct 31]. Available from: http://portal.anvisa.gov.br/resultado-de-busca?p_p_id=101&p_p_lifecycle=0&p_p_state=maximized&p_p_mode=view&p_p_col_id=column1&p_p_col_count=1&_101_struts_action=%2Fasset_publisher%2Fview_content&_101_assetEntryId=584443&_101_type=content&_101_groupId=33
Amorim MAL, Cardoso MA. A Farmacovigilância e sua importância no monitoramento das reações adversas a medicamentos. Rev Saúde e Desenvolv. 2013;4(2):33‑56.
Mota DM, Vigo Á, Kuchenbecker R de S. Recomendação de códigos da CID-10 para vigilância de reações adversas e intoxicações a medicamentos. Cien Saude Colet. 2018;23(9):3041–54. DOI: 10.1590/1413-81232018239.20692016
Senst BL, Achusim LE, Genest RP, et al. Practical approach to determining costs and frequency of adverse drug events in a health care network. Am J Heal Pharm. 2001;58(12):1126–32. DOI: 10.1093/ajhp/58.12.1126
Louro E, Romano-Lieber NS, Ribeiro E. Eventos adversos a antibióticos em pacientes internados em um hospital universitário. Rev Saude Publica. 2007;41(6):1042–8. DOI: 10.1590/S0034-89102006005000049
ASCOM/ANVISA. Eventos adversos: Anvisa lançará VigiMed em dezembro - Notícias [Internet]. portal anvisa. 2018 [cited 2019 Nov 1]. Available from: http://portal.anvisa.gov.br/noticias/-/asset_publisher/FXrpx9qY7FbU/content/eventos-adversos-anvisa-lancara-vigimed-em-dezembro/219201/pop_up?_101_INSTANCE_FXrpx9qY7FbU_viewMode=print&_101_INSTANCE_FXrpx9qY7FbU_languageId=pt_BR
ANVISA. VigiMed - Anvisa [Internet]. [cited 2019 Nov 2]. Available from: http://portal.anvisa.gov.br/vigimed
de Lima MES, Reis CAR, Araújo AEP et al. Perfil de reações adversas relacionadas a medicamentos de um hospital sentinela em Fortaleza - Ceará. In: Anais do Encontro do Programa de Pós-Graduação em Ciências Farmacêuticas. 2017. DOI: 10.17648/ppgcf-2017-66390
De Souza AC, Dos Santos Almeida FV, Elias SC, et al. Uso da vitamina K como rastreador de eventos adversos hemorragicos por varfarina: Um estudo de caso. Rev Ciencias Farm Basica e Apl. 2014;35(3):451–7.
Stockwell DC, Bisarya H, Classen DC, et al. A trigger tool to detect harm in pediatric inpatient settings. Pediatrics. 2015;135(6):1036–42. DOI: 10.1542/peds.2014-2152.
Naranjo CA, Busto U, Sellers EM, et al. Method for estimatingthe probability of adverse drug reactions.Clinical Pharmacology & Therapeutics. 1981; 30(2), 239-245.
Giordani F, Rozenfeld S, de Oliveira DFM, et al. Vigilância de eventos adversos a medicamentos em hospitais: Aplicação e desempenho de rastreadores. Vol. 15, Revista Brasileira de Epidemiologia. Associação Brasileira de Saúde Coletiva; 2012. p. 455–67. DOI: 10.1590/S1415-790X2012000300002
ANVISA, Bulário Eletrônico, 2013 [Internet]. [cited 2019 Nov 11]. Available from: http://www.anvisa.gov.br/datavisa/fila_bula/frmResultado.asp
D’Aquino FFR, Juliani CMCM, Lima SAM, et al. Incidentes relacionados a medicamentos em uma instituição hospitalar: subsídios para a melhoria da gestão. Rev Enferm UERJ. 2015;23(5):616–21. DOI: 10.12957/reuerj.2015.10637
Mota DM, Vigo Á, Kuchenbecker R de S. Reações adversas a medicamentos no sistema de farmacovigilância do Brasil, 2008 a 2013: estudo descritivo. Cad Saude Publica. 2019;35(8):e00148818. DOI: 10.1590/0102-311X00148818
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Authors
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
The authors hereby transfer, assign, or otherwise convey to RBFHSS: (1) the right to grant permission to republish or reprint the stated material, in whole or in part, without a fee; (2) the right to print republish copies for free distribution or sale; and (3) the right to republish the stated material in any format (electronic or printed). In addition, the undersigned affirms that the article described above has not previously been published, in whole or part, is not subject to copyright or other rights except by the author(s), and has not been submitted for publication elsewhere, except as communicated in writing to RHFHSS with this document.
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC-BY-NC-ND) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Serlf-archiving policy
This journal permits and encourages authors to post and archive the final pdf of the articles submitted to the journal on personal websites or institutional repositories after publication, while providing bibliographic details that credit its publication in this journal.
